Market
  • Company Info.

    Unichem Laboratories Ltd.

    Income Statement - Consolidated



    Market Cap.(`) 4121.20 Cr. P/BV 1.70 Book Value (`) 344.18
    52 Week High/Low ( ` ) 607/367 FV/ML 2/1 P/E(X) 0.00
    Book Closure 09/08/2022 EPS (`) 0.00 Div Yield (%) 0.00


    (` in Crs.)
    You can view the Consolidated Income Statement for the last 5 years.

    ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
    Months1212121212
    Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
    FaceValue2.002.002.002.002.00
          
          
    INCOME     
    Revenue From Operations [Net]1302.421247.981189.921049.581122.77
    Other Operating Revenues40.6021.8545.2254.1357.28
    Total Operating Revenues1343.021269.831235.141103.711180.05
          
    Other Income38.5247.5150.1991.3198.41
    Total Revenue1381.541317.341285.321195.031278.46
          
    EXPENSES     
    Cost Of Materials Consumed532.20456.01466.99421.88476.92
    Purchase Of Stock-In Trade1.531.350.541.040.21
    Changes In Inventories Of FG,WIP And Stock-In Trade17.20-41.53-88.14-35.76-32.48
    Employee Benefit Expenses356.41330.49306.97273.28239.32
    Finance Costs17.316.115.127.857.52
    Provisions And Contingencies3.427.240.000.000.00
    Depreciation And Amortisation Expenses113.4491.1784.3681.6767.37
    Other Expenses477.82443.48457.67494.09579.57
    Total Expenses1519.331294.311233.501244.051338.43
          
    Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-137.8023.0351.82-49.02-59.97
          
    Profit/Loss Before Tax-137.8023.0351.82-49.02-59.97
          
    Tax Expenses-Continued Operations     
    Current Tax11.0610.5116.685.477.14
    Deferred Tax15.35-21.84-0.156.50-40.24
    Tax For Earlier Years-0.540.240.620.00-1.24
    Total Tax Expenses25.86-11.0917.1511.97-34.35
    Profit/Loss After Tax And Before ExtraOrdinary Items-163.6634.1234.67-61.00-25.62
          
    Profit/Loss From Continuing Operations-163.6634.1234.67-61.00-25.62
          
    Profit/Loss From Discontinuing Operations0.000.000.000.002.47
    Total Tax Expenses Discontinuing Operations0.000.000.000.000.71
    Net Profit/Loss From Discontinuing Operations0.000.000.000.001.76
    Profit/Loss For The Period-163.6634.1234.67-61.00-23.87
    Share Of Profit/Loss Of Associates-38.57-1.06-0.340.810.07
    Consolidated Profit/Loss After MI And Associates-202.2333.0634.32-60.18-23.80
          
    OTHER INFORMATION     
          
    EARNINGS PER SHARE     
    Basic EPS (Rs.)-28.724.704.88-8.55-3.38
    Diluted EPS (Rs.)-28.724.704.88-8.55-3.38
          
    DIVIDEND AND DIVIDEND PERCENTAGE     
    Equity Share Dividend0.0028.1628.1633.950.00
  • Unichem Laboratories Ltd.

    Balance Sheet - Consolidated



    Market Cap.(`) 4121.20 Cr. P/BV 1.70 Book Value (`) 344.18
    52 Week High/Low ( ` ) 607/367 FV/ML 2/1 P/E(X) 0.00
    Book Closure 09/08/2022 EPS (`) 0.00 Div Yield (%) 0.00


    (` in Crs.)
    You can view the Consolidated Balance Sheet for the last 5 years.

    ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
    Months1212121212
    Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
    FaceValue2.002.002.002.002.00
    No. of Equity Shares (in Lacs)704.06704.06704.06704.06703.83
          
    EQUITIES AND LIABILITIES     
    SHAREHOLDER'S FUNDS     
    Equity Share Capital14.0814.0814.0814.0814.08
    Total Share Capital14.0814.0814.0814.0814.08
          
    Reserves and Surplus2409.182593.652535.002512.442601.99
    Total Reserves and Surplus2409.182593.652535.002512.442601.99
    Employees Stock Options12.0510.687.754.833.84
    Total Shareholders Funds2435.302618.412556.832531.352619.91
          
    NON-CURRENT LIABILITIES     
    Long Term Borrowings63.6589.010.000.000.00
    Deferred Tax Liabilities [Net]0.000.0013.700.007.50
    Other Long Term Liabilities12.5919.2619.0023.154.69
    Long Term Provisions41.9139.9630.4123.5114.60
    Total Non-Current Liabilities118.14148.2463.1246.6626.79
          
    CURRENT LIABILITIES     
    Short Term Borrowings233.74241.35100.63184.03199.67
    Trade Payables290.69183.19210.08250.22221.41
    Other Current Liabilities103.16111.50180.23122.6770.60
    Short Term Provisions12.0116.0914.839.8111.25
    Total Current Liabilities639.60552.13505.76566.73502.92
          
    Total Capital And Liabilities3193.053318.773125.713144.743149.61
          
    ASSETS     
    NON-CURRENT ASSETS     
    Tangible Assets1255.12988.49882.41868.11808.16
    Intangible Assets0.000.000.000.000.25
    Capital Work-In-Progress147.45493.81567.50330.4792.39
    Fixed Assets1402.571482.301449.911198.58900.79
    Goodwill On Consolidation1.551.551.551.551.55
    Non-Current Investments0.160.28155.59130.78125.54
    Deferred Tax Assets [Net]10.114.3613.952.9416.68
    Long Term Loans And Advances0.130.120.070.080.06
    Other Non-Current Assets186.66181.78127.33124.3565.70
    Total Non-Current Assets1601.171670.381748.401458.271110.33
          
          
    CURRENT ASSETS     
    Current Investments1.54263.58236.43419.10800.75
    Inventories625.23600.22538.34396.54338.66
    Trade Receivables588.62495.43250.27390.14436.05
    Cash And Cash Equivalents185.36114.1082.45233.81200.99
    Short Term Loans And Advances0.060.050.040.040.06
    OtherCurrentAssets191.07175.01269.78246.83262.77
    Total Current Assets1591.881648.391377.321686.472039.29
          
    Total Assets3193.053318.773125.713144.743149.61
          
    OTHER INFORMATION     
          
    CONTINGENT LIABILITIES, COMMITMENTS     
    Contingent Liabilities151.04145.39561.98397.10432.75
          
    BONUS DETAILS     
    Bonus Equity Share Capital11.3611.3611.3611.3611.37
          
    NON-CURRENT INVESTMENTS     
    Non-Current Investments Quoted Market Value0.140.260.150.040.06
    Non-Current Investments Unquoted Book Value0.020.02155.44130.74125.49
          
    CURRENT INVESTMENTS     
    Current Investments Quoted Market Value1.25263.58236.43419.100.00
    Current Investments Unquoted Book Value0.290.000.000.00800.75
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html